| NOBEL Pharma Schweiz AG - Rivaroxaban NOBEL 15 mg, Filmtabletten | | 68009 | | 02 | | Rivaroxaban NOBEL 15 mg | | Filmtabletten | | B01AF01 | | Rivaroxaban | | 28.04.2022 | | |
| | Composition | | rivaroxabanum 15 mg, mannitolum, carmellosum natricum conexum, hypromellosum, natrii laurilsulfas, cellulosum microcristallinum, magnesii stearas, Überzug: hypromellosum, macrogolum 3350, E 171, E 172 (rubrum), pro compresso obducto corresp. natrium max. 0.3292 mg. | | Packungsbestandteile | | Comprimés filmés | | | | Principe actif | Concentr. |
|---|
| Rivaroxabanum | 15 mg |
| | | | Agents auxilliaires | Concentr. | informations additionels |
|---|
| (Rubrum) | | | | Carmellosum Natricum Conexum | | | | Cellulosum Microcristallinum | | | | E 171 | | color. | | E 172 | | color. | | Hypromellosum | | Überzug | | Macrogol | 3350 | | | Magnesii Stearas | | | | Mannitol | | | | Natrii Laurilsulfas | | | | Pro Compresso Obducto | | |
|
| |
|
